Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in inventions in biomaterials
4.1.2 Rise in ageing population
4.1.3 High per capita income
4.2 Restraints
4.2.1 Compatibility issues
4.2.2 Safety regulations
4.3 Opportunities
4.3.1 Growing Healthcare industry
4.3.2 Increase in free-trades
4.4 Challenges
4.4.1. Limitations of biomaterial products
Chapter 5 Biomaterial Market - By Specialty
5.1 Cardiology
5.2 Neurology
5.3 Orthopaedics
5.4 Dental
5.5 Gynaecology
5.6 Others
Chapter 6 Biomaterial Market - By Type of Material
6.1 Bioactive material
6.2 Bioinert material
6.3 Bioresorbable material
Chapter 7 Biomaterial Market - By Geography
7.1 Introduction
7.2 North America
7.2.1. The U.S.
7.2.2. Canada
7.2.3. Mexico
7.3 Europe
7.3.1. U.K.
7.3.2. Germany
7.3.3. France
7.3.4. Italy
7.3.5. Spain
7.3.6. Rest of Europe
7.4 Asia Pacific
7.4.1. China
7.4.2. India
7.4.3. Japan
7.4.4. South Korea
7.4.5. Australia & New Zealand
7.4.6. Rest of APAC
7.5 South America
7.5.1. Brazil
7.5.2. Argentina
7.5.3. Others
7.6. The Middle East & Africa
7.6.1. The Middle East
7.6.2. Africa
Chapter 8 Biomaterial Market - Company Profiles
8.1. Celsense Corporation
8.2. DuPont
8.3. Biomet, Inc.
8.4. Zimmer Biomet Holdings, Inc.
8.5. Wright Medical Group, Inc.
8.6. Invibio Ltd.
8.7. BASF SE
8.8. Dentsply
8.9. Bayer AG
8.10. AdvanSource Biomaterials Corp
8.11. Oasmia
8.12. Midatech
8.13. Corbion N.V.
8.14. Royal DSM
8.15. Berkeley Advanced Biomaterials, Inc.
Chapter 9 Biomaterial Market - Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 10 Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
